Clinical Trial Update: A Study to Investigate CYC140, in Subjects With Advanced Solid Tumors and Lymphoma [Phase 1, Phase 2]

View source ↗

Summary

A study investigating CYC140 in subjects with advanced solid tumors and lymphoma (Phase 1/Phase 2) is listed with unknown status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lymphoma
• Solid Tumor

Drugs mentioned

• CYC140

Snippet

Sponsor: Cyclacel Pharmaceuticals, Inc. | Conditions: Solid Tumor, Adult Lymphoma | Phase 1, Phase 2 | Status: UNKNOWN